BofA Finance LLC has announced the filing of a pricing supplement for its new Auto-Callable Yield Notes linked to the common stock of Tesla, Inc. This financial product is designed to provide contingent income with a memory feature, allowing for potential returns based on Tesla's stock performance.
The significance of this filing lies in BofA Finance's strategy to broaden its investment offerings. The Auto-Callable Yield Notes are expected to price on November 13, 2026, and are set to issue on November 18, 2026. This move reflects a growing trend in the national commercial banking sector, as institutions seek innovative ways to attract investors.
Background
BofA Finance LLC operates under the SIC code 6021, which identifies it as part of the national commercial banks segment. The company is a subsidiary of Bank of America Corporation, which is also based in Charlotte, North Carolina. BofA Finance is incorporated in Delaware and has a fiscal year ending on December 31. The firm has recently filed multiple pricing supplements, indicating a robust pipeline of investment products.
What the Filing Says
The filing, dated November 12, 2026, outlines that the Auto-Callable Yield Notes will have an approximate two-year term unless called prior to maturity. The notes are fully and unconditionally guaranteed by Bank of America Corporation. The expected pricing date for these notes is November 13, 2026, with a maturity date set for November 16, 2028.
Impact
This new offering may affect a range of stakeholders, including investors looking for innovative financial products and competitors in the national commercial banking space. The Auto-Callable Yield Notes are linked to Tesla's stock performance, which could attract investors interested in exposure to the electric vehicle market.
What's Next
Following this filing, BofA Finance is expected to finalize the pricing of the notes on November 13, 2026. The filing does not specify any further actions beyond this date.
Read Next
Dominion Energy announces $1.2 billion senior notes issuance
Lakefront Biotherapeutics Launches €50 Million Share Buyback
Coca-Cola Europacific Partners Announces Share Buyback Details
Zenta Group announces $6.47 million at-the-market offering
MapLight Therapeutics Enters $100 Million Sales Agreement
Cyabra, Inc. Secures $15.6 Million in Private Placement










